- Presentations
- 5
- Markets
- 2
Hyrimoz is a brand of Adalimumab marketed by Sandoz, with 5 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Adalimumab
- Brand owner
- Sandoz
- Registered in
- European Union, United States
- Strengths and forms
- 10 mg/0.1 mL injection, 20 mg/0.2 mL injection, 40 mg/0.4 mL injection, 80 mg/0.8 mL injection, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Hyrimoz 10 mg/0.1 mL injectionSubcutaneous Cold chain | Sandoz | US FDA | Available on request |
| Hyrimoz 20 mg/0.2 mL injectionSubcutaneous Cold chain | Sandoz | US FDA | Available on request |
| Hyrimoz 40 mg/0.4 mL injectionSubcutaneous Cold chain | Sandoz | US FDA | Available on request |
| Hyrimoz 80 mg/0.8 mL injectionSubcutaneous Cold chain | Sandoz | US FDA | Available on request |
| Hyrimoz kit Cold chain | Sandoz | US FDA | Available on request |
Equivalent brands
Other brands of Adalimumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Hyrimoz
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.